• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Wei,GAO Tianshu,TANG Tongjun,JIA Yuhan,PEI Naiqi,QIAO Youqiao,ZHAO Jiaxin,DING Xiaopeng,GE Hao,ZHANG Bo,LI Honglei,WANG Xing.Effect and mechanism of N-9,10-anthraquinone-2-formyl phenylalanine on gouty arthritis in rats[J].Journal Of Pharmaceutical Research,2023,42(5):303-309[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3186times   Download 2669次 QR Code for this article
Scan with your phone!
N-9,10-蒽醌-2-甲酰基苯丙氨酸治疗大鼠痛风性关节炎的作用及机制
王伟1,高天舒2,汤同军1,贾昱晗2,裴乃琪3,钱有桥4,赵嘉鑫2,丁骁鹏1,葛昊1,张波1,李洪雷5,王星2
Font:Larger+|Default|Smaller-
(1.句容市人民医院骨科,江苏 句容 212400;2.中国药科大学药学院药理系,江苏 南京 211198;3.中国药科大学基础医学与临床药学学院,江苏 南京 211198;4.中国药科大学中药学院,江苏 南京 211198;5.南京医科大学康达学院药学部,江苏 连云港 222000)
摘要:
目的 探究N-9,10-蒽醌-2-甲酰基苯丙氨酸(NAY)对尿酸钠(MSU)所致痛风性关节炎(GA)大鼠的作用及机制。方法 将雄性SD大鼠随机分为7组,每组8只,即正常组、模型组、NAY低(20 mg·kg-1)、中(40 mg·kg-1)、高剂量组(80 mg·kg-1)、秋水仙碱组(0.8 mg·kg-1)和别嘌呤醇组(10 mg·kg-1),通过关节腔内注射MSU晶体建立大鼠急性GA模型,各组灌胃给药5 d,给药第三天造模。将原代培养的大鼠腹部巨噬细胞分成空白组、模型组、NAY组、MCC950组和联合给药组。软尺测量大鼠踝关节周长并计算大鼠关节肿胀度;检测大鼠血清尿酸(UA)、肌酐(CRE)和尿素氮(BUN)含量;HE染色观察大鼠踝关节滑膜组织病理切片;检测各组血清、关节滑膜和细胞上清液中肿瘤坏死因子-α(TNF-α)和白介素-1β(IL-1β)的含量;并检测各组关节滑膜和细胞中NOD样受体热蛋白结构域相关蛋白3(NLRP3)、凋亡相关斑点样蛋白(ASC)和半胱氨酸天冬氨酸蛋白酶-1(Caspase-1)的蛋白表达。结果 动物实验发现,与模型组相比,NAY给药组在造模12 h、24 h和48 h均可不同程度改善GA大鼠踝关节肿胀度,且NAY各个剂量组均显著降低GA大鼠血清UA、CRE和BUN水平,同时显著降低GA大鼠血清中TNF-α水平及GA大鼠关节滑膜中炎症因子TNF-α水平和IL-1β水平,而NAY能显著降低GA大鼠关节滑膜中NLRP3、ASC和Caspase-1的蛋白表达,HE染色结果显示NAY可减轻GA模型大鼠踝关节滑膜组织炎性细胞浸润,改善细胞形态。细胞实验发现,NAY、MCC950和联合给药组均可显著提高MSU诱导大鼠巨噬细胞活力,降低上清液TNF-α和IL-1β的含量,并显著降低模型组NLRP3、ASC和Caspase-1蛋白表达,但是联合给药组与MCC950组相比,上述指标没有显著性差异。结论 NAY可在体内和体外有效预防MSU晶体诱导的GA,机制可能与其降尿酸和抑制NLRP3炎症小体表达有关。
关键词:  痛风性关节炎  N-9,10-蒽醌-2-甲酰基苯丙氨酸  黄嘌呤氧化酶抑制剂  尿酸钠  NLRP3炎症小体
DOI:10.13506/j.cnki.jpr.2023.05.003
基金项目:2018年度镇江市社会发展指导性项目(No.FZ2018014);2018年度句容市民生科技计划项目(No.SF2018013987);江苏省基础研究计划(自然科学基金)-青年基金项目(No.BK20180574);南京医科大学康达学院2021年度科研发展基金(No.KD2021KYJJZD009)
Publication Date:May 25, 2023
Effect and mechanism of N-9,10-anthraquinone-2-formyl phenylalanine on gouty arthritis in rats
WANG Wei1,GAO Tianshu2,TANG Tongjun1,JIA Yuhan2,PEI Naiqi3,QIAO Youqiao4,ZHAO Jiaxin2,DING Xiaopeng1,GE Hao1,ZHANG Bo1,LI Honglei5,WANG Xing2
(1.Department of Orthopedics, The People's Hospital of Jurong, Jurong 212400,China; 2.Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211198,China; 3.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198,China; 4.School of Traditional Chinese Pharmacy,China Pharmaceutical University, Nanjing 211198; 5.Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000,China)
Abstract:
Objective To explore the effect and mechanism of N-9,10-anthraquinone-2-formyl phenylalanine (NAY) on gouty arthritis (GA) rats induced by sodium urate (monosodium urate).Methods Male SD rats were randomly divided into 7 groups: 8 each, namely normal group, model group, NAY low (20 mg·kg-1), medium (40 mg·kg-1), high dose group (80 mg·kg-1), colchicine group (0.8 mg·kg-1) and allopurinol group (10 mg·kg-1). Rat acute GA model was established by intra-articular injection of MSU crystals. Each group was administered for 5 days and molded on the third day. The primary cultured rat abdominal macrophages were divided into blank group, model group, NAY group, MCC950 group, co-administration group. Measure the circumference of the rat ankle joint with a soft ruler and calculate the swelling degree of the rat joint. Serum samples of rats were collected to detect the contents of serum uric acid (UA), creatinine (CRE) and urea nitrogen (BUN). HE staining was used to observe the pathological sections of the synovium of the ankle joint of rats. The contents of tumor necrosis factor- α (TNF- α) and interleukin-1β (IL-1β) were measured in serum, synovial membrane and cell supernatant of each group. The protein expressions of NOD-like receptor family pyrin domain-containing 3 (NLRP3), apoptosis-associated speck-like protein containing CARD (ASC) and cysteinyl aspartate-specific proteases-1 (Caspase-1) were detected in synovium and cells of each group.Results As found in animal experiments, the NAY administration group could improve the ankle swelling of GA rats in different degrees at 12 hours, 24 hours and 48 hours, and each dose group of NAY can significantly reduce serum UA, CRE and BUN levels in GA rats, while significantly reducing TNF-α and IL-1β levels in serum with the decrease of TNF-α and IL-1β levels in the synovial membrane. In addition, NAY could significantly reduce the protein expression of NLRP3, ASC and Caspase-1 in the synovium of the ankle joint of GA rats. HE staining results showed that NAY can reduce inflammatory cell infiltration and improve cell morphology in the ankle joint synovial tissue of GA model rats. Cell experiment showed that NAY, MCC950 and combined administration group could significantly increase the cell activity of rat macrophages induced by MSU, reduce the expression of TNF-α and IL-1β in the supernatant, and significantly reduce NLRP3, ASC and Caspase-1 protein expression compared with the model group, but there was no significant difference in the above indexes between the combined administration group and MCC950 group. Conclusion NAY effectively prevents MSU crystal-induced GA in vitro and in vivo, and the mechanism may be related to its uric acid lowering and inhibition of NLRP3 inflammasome expression.
Key words:  Gouty arthritis  N-9,10-anthraquinone-2-formyl phenylalanine  Xanthine oxidase inhibitor  Monosodium urate  NLRP3 inflammasome
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.